Adaptive Pharmacogenomics, LLC

Clinical development for personalized medicine

Saturday, May 19, 2012 | 7:26 PM

Statistical considerations in evaluating pharmacogenomics-based clinical effect for confirmatory trials.

Statistical considerations in evaluating pharmacogenomics-based clinical effect for confirmatory trials.

Clin Trials. 2010 Oct;7(5):525-36

Authors: Wang SJ, O'Neill RT, Hung HJ

The current practice for seeking genomically favorable patients in randomized controlled clinical trials using genomic convenience samples.

PMID: 20595242 [PubMed - indexed for MEDLINE]

Jan 30, 2011 03:23 AMwww.ncbi.nlm.nih.gov
© 2008 — 2012 Adaptive Pharmacogenomics, LLC